Anfarma SRL
The score of Anfarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +14 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Anfarma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 45,663 € | ||||
| Equity | 333,952 € | ||||
| Cash | 135,450 € | ||||
| EBITDA | 86,418 € | ||||
| Total assets | 386,780 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jun 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Anfarma's financial analysis
- Solvency86.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Anfarma
Anfarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0832.066.295
- VAT number
- BE0832066295
- Peppol
- Registered · 0208:0832066295 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Dec 2010
- Registered office
- 2018 Antwerp
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Anfarma (SRL) has been based in Antwerp since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 45,663 € and equity of 333,952 €; its revenue is not published. Its solvency stands at 86.3%, above the median of its sector (44.2%).
Companies similar to Anfarma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Bouakka Retail sale of pharmaceutical products Antwerp · balance sheet 394,063 €
- Pharmacie Besonrieux Centre Retail sale of pharmaceutical products La Louvière · balance sheet 377,209 €
- J-C Grace Pharmacy Retail sale of pharmaceutical products Brussels · balance sheet 386,831 €
- ParaPharmacie de Recogne Retail sale of pharmaceutical products Libramont-Chevigny · balance sheet 386,531 €
- Les Pharmacies Réunies Retail sale of pharmaceutical products Frameries · balance sheet 389,988 €
- Koltfarma Retail sale of pharmaceutical products Charleroi · balance sheet 488,225 €
- Pharmalys Retail sale of pharmaceutical products Farciennes · balance sheet 392,320 €
- P. Radoux Retail sale of pharmaceutical products Liège · balance sheet 381,087 €
Frequently asked questions about Anfarma
What is the revenue of Anfarma?
Anfarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Anfarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0832066295 for Anfarma, if the company is VAT-registered. Its company number (CBE) is 0832.066.295.
Where is the registered office of Anfarma?
According to the CBE register, the registered office of Anfarma is in 2018 Antwerp.
What is the equity of Anfarma?
At the close of the 2025 financial year, the equity of Anfarma amounts to 333,952 €, a solvency of 86.3% of total assets.
Who manages Anfarma?
The register lists 1 active mandates at Anfarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Anfarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →